Summary: H.R.3253 — 116th Congress (2019-2020)All Information (Except Text)

Bill summaries are authored by CRS.

Shown Here:
Passed House (06/18/2019)

Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019

This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill

  • makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program;
  • allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings;
  • temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services;
  • temporarily extends the Medicaid demonstration program for certified community behavioral health clinics;
  • repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and
  • increases funding available to the Medicaid Improvement Fund beginning in FY2021.